Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.62 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29644319 | 1.00 | LPL (0.62) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL2708689 | 0.96 | LPL (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL4299809 | 0.96 | LPL (0.59) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL29387132 | 0.93 | LPL (0.61) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL1294059 | 0.93 | LPL (0.61) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL29392121 | 0.92 | LPL (0.75) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL120527 | 0.92 | LPL (0.75) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL12654466 | 0.90 | LPL (0.54) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL13142480 | 0.90 | LPL (0.68) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL6126262 | 0.90 | LPL (0.53) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12049542-B2 | Polymers for use in electronic devices | DUPONT ELECTRONICS, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| CN-117069921-B | High-performance membrane material and preparation method and application thereof | 烟台九目化学股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117069921-A | High-performance membrane material and preparation method and application thereof | 烟台九目化学股份有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-20230345829-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
| US-20230345829-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
| US-11800800-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800800-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| EP-3778570-B1 | STRONGLY-POLARIZED MOLECULE, AND SINGLE MOLECULE FIELD EFFECT TRANSISTOR PREPARED THEREFROM | UNIV BEIJING (CN) | 2023-10-04 | — | — | EP | disclosed |
| EP-2764034-B1 | POLYMERS BASED ON BENZODIONES | CLAP CO LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| EP-2764034-B1 | POLYMERS BASED ON BENZODIONES | CLAP CO LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| WO-2011059850-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011059887-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011059887-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011059850-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011025455-A1 | P-TYPE MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-03-03 | — | — | WO | disclosed |
| WO-2011025455-A1 | P-TYPE MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-03-03 | — | — | WO | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230345829-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | OR51E2, ETV6, OR10J3 | LPL 1528/4885LIPG 1711/4885CA1 2556/4885 |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | GTF2I, FLI1, GLB1 | LPL 431/4885LIPG 983/4885CA1 3333/4885 |
| US-11800800-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | OR51E2, ETV6, OR10J3 | LPL 1528/4885LIPG 1711/4885CA1 2556/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | LPL 2383/4885LIPG 1280/4885CA1 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.